bpc 157 thorne bpc-157 scottsdale Home Page BPC-157 Peptide Therapy Chicago Apeiron Elementals BPC-157 + T

Benefits Appetite suppressant Promotes sensation of fullness Can be taken alone, or in combination with GLP1, to promote weight loss Currently in Phase III clinical trial (RENEW2) evaluating its effect on obesity and diabetes as monotherapy Currently in Phase III clinical trial (REDEFINE3) evaluating its effect on cardiovascular health, when combined with Semaglutide Dosing Subcutnaeous 0.6 mg 4.8 mg Once a Week Any time of day SEMAGLUTIDE Synthetic polypeptide

Younger individuals with a significant family history or other predisposing factors may warrant earlier or more intensive screening protocols

Hold the vial up to good light and inspect before use

The active ingredient is identical, so the transition is straightforward

Sanitize the stopper and use sterile technique